18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

about

Determination of binding affinity of molecular imaging agents for steroid hormone receptors in breast cancer.

P2860

Q55069738-263E4AE7-33F6-45F6-9A45-501A0A14926E

P2860

18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

Item

http://www.wikidata.org/entity/Q47732227

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@en

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@nl

type

Item

label

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@en

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@nl

prefLabel

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@en

18F-16α-17β-Fluoroestradiol Bi ...... ceptor-Positive Breast Cancer.

@nl

P1476

18F-16α-17β-Fluoroestradiol Bi ...... eceptor-Positive Breast Cancer

@en

P2093

Amy M Fowler

http://www.w3.org/2001/XMLSchema#string

Aparna M Mahajan

http://www.w3.org/2001/XMLSchema#string

Ginny L Powers

http://www.w3.org/2001/XMLSchema#string

Justin J Jeffery

http://www.w3.org/2001/XMLSchema#string

Kelley Salem

http://www.w3.org/2001/XMLSchema#string

Yongjun Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer.

Optimization of the preparation of fluorine-18-labeled steroid receptor ligands 16alpha-[18F]fluoroestradiol (FES), [18F]fluoro furanyl norprogesterone (FFNP), and 16beta-[18F]fluoro-5alpha-dihydrotestosterone (FDHT) as radiopharmaceuticals.

Fluoroestradiol positron emission tomography reveals differences in pharmacodynamics of aromatase inhibitors, tamoxifen, and fulvestrant in patients with metastatic breast cancer.

Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.

Pharmacodynamic imaging guides dosing of a selective estrogen receptor degrader

Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.

ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.

Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.

PET imaging of oestrogen receptors in patients with breast cancer.

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor.

P304

856-864

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2017162956

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

286

http://www.w3.org/2001/XMLSchema#string

P50

Manoj Kumar

P577

2017-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28956736

http://www.w3.org/2001/XMLSchema#string

P921

estrogen-receptor positive breast cancer

P932

5882239

http://www.w3.org/2001/XMLSchema#string

18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

about

P2860

P2860

18F-16α-17β-Fluoroestradiol Binding Specificity in Estrogen Receptor-Positive Breast Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932